Migræne kliniske forsøg i Virginia
7 studier for Migræne søger deltagere på steder i Virginia.
Byer i Virginia
Officiel studietekst (engelsk)
Study of EVO756 in Adults With Migraine
- MedStar Health: Headache Center at McLean, McLean
RekruttererFase 2
Alder 18 til 64 · Alle køn · Opdateret 2. okt. 2026 · NCT07616128Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- og 2 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
- Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
- Pediatric Research of Charlottesville, LLC, Charlottesville
- og 2 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 24. sep. 2026 · NCT04649242Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
- Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 230581, Norfolk
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 14. sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Health Research of Hampton Roads, Inc. (HRHR), Newport News
- AMR Clinical - Norfolk, Norfolk
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 20. aug. 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Children's Specialty Group - 3 Commercial Place, Norfolk
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 12. jun. 2026 · NCT05164172Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
- MedStar Health: Neurology at McLean, McLean
RekruttererFase 4
Alder 18 og opefter · Alle køn · Opdateret 24. dec. 2025 · NCT07301008Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.